123 related articles for article (PubMed ID: 37469279)
21. Embryonic vasculogenesis in nodular melanomas and tumour differentiation.
Iyengar B; Singh AV
Pathol Oncol Res; 2011 Sep; 17(3):569-77. PubMed ID: 21203906
[TBL] [Abstract][Full Text] [Related]
22. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
[TBL] [Abstract][Full Text] [Related]
23. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
24. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
25. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V; Adam RL; de Sá BC; Landman G; Metze K
BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
27. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.
Baer SC; Schultz D; Synnestvedt M; Elder DE
Cancer; 1995 Dec; 76(11):2242-7. PubMed ID: 8635027
[TBL] [Abstract][Full Text] [Related]
28. Implementation of the 7th edition AJCC staging system: Effects on staging and survival for pT1 melanoma. A Dutch population based study.
Oude Ophuis CM; Louwman MW; Grünhagen DJ; Verhoef K; van Akkooi AC
Int J Cancer; 2017 Apr; 140(8):1802-1808. PubMed ID: 28109000
[TBL] [Abstract][Full Text] [Related]
29. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
30. The causes of nail apparatus pigmentation presenting to a melanoma screening clinic a prospective study.
Alani A; Blasdale C; Oliphant T; Hackett C; Langtry JAA
Clin Exp Dermatol; 2019 Aug; 44(6):625-630. PubMed ID: 30706554
[TBL] [Abstract][Full Text] [Related]
31. A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Isaksson K; Katsarelias D; Mikiver R; Carneiro A; Ny L; Olofsson Bagge R
Ann Surg Oncol; 2019 Sep; 26(9):2839-2845. PubMed ID: 31111349
[TBL] [Abstract][Full Text] [Related]
32. Amelanotic malignant melanomas of the oral mucosa.
Notani K; Shindoh M; Yamazaki Y; Nakamura H; Watanabe M; Kogoh T; Ferguson MM; Fukuda H
Br J Oral Maxillofac Surg; 2002 Jun; 40(3):195-200. PubMed ID: 12054708
[TBL] [Abstract][Full Text] [Related]
33. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
34. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
35. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study.
Savoia P; Osella-Abate S; Deboli T; Marenco F; Stroppiana E; Novelli M; Fierro MT; Bernengo MG
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):882-8. PubMed ID: 21819449
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
38. Vascular invasion in malignant melanomas. An independent prognostic variable?
Fallowfield ME; Cook MG
Am J Surg Pathol; 1989 Mar; 13(3):217-20. PubMed ID: 2919719
[TBL] [Abstract][Full Text] [Related]
39. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
40. Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination.
Gibson LE; Goellner JR
Mayo Clin Proc; 1988 Aug; 63(8):777-82. PubMed ID: 2456432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
